TY  - JOUR 
AU  - Hernández-Boluda, J. C.
AU  - Arellano-Rodrigo, E.
AU  - Cervantes, F.
AU  - Alvarez-Larrán, A.
AU  - Gómez, M.
AU  - Barba, P.
AU  - Mata, M. I.
AU  - González-Porras, J. R.
AU  - Ferrer-Marín, F.
AU  - García-Gutiérrez, V.
AU  - Magro, E.
AU  - Moreno, M.
AU  - Kerguelen, A.
AU  - Pérez Encinas, Manuel Mateo
AU  - Kerguelen, A.
AU  - Estrada, N.
AU  - Ayala, R.
AU  - Besses, C.
AU  - Pereira, A.
PY  - 2015
SN  - 0939-5555
UR  - http://hdl.handle.net/20.500.11940/8239
AB  - [EN] It is unclear whether anticoagulation guidelines intended for the general population are applicable to patients with polycythemia vera (PV) and essential thrombocythemia (ET). In the present study, the risk of thrombotic recurrence was analyzed...
LA  - eng
KW  - Anticoagulants
KW  - Polycythemia Vera
KW  - Thrombocythemia, Essential
KW  - Thrombosis
TI  - Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
DO  - 10.1007/s00277-015-2330-2
T2  - ANNALS OF HEMATOLOGY
M2  - 911
VL  - 94
ER  -